论文部分内容阅读
目的观察布地奈德联合沙丁胺醇雾化治疗成人哮喘的临床疗效与安全性。方法将60例哮喘患者随机分为两组,两组患者哮喘常规治疗相同,治疗组在此基础上雾化吸入布地奈德和沙丁胺醇。对两组的动脉血气、临床有效率、临床主要症状缓解时间、肺功能、激素用量等进行评价。结果治疗组于治疗后1 d、7 d动脉血气分析指标、临床有效率、临床主要症状缓解时间、肺功能、激素用量明显优于对照组(P<0.05)。治疗组无一例出现不良反应。结论布地奈德联合沙丁胺醇雾化能明显改善哮喘症状,无明显不良反应,值得临床推广应用。
Objective To observe the clinical efficacy and safety of budesonide combined with salbutamol nebulization in the treatment of adult asthma. Methods Sixty patients with asthma were randomly divided into two groups. The routine treatment of asthma in both groups was the same. The treatment group inhaled budesonide and salbutamol on the basis of this method. The two groups of arterial blood gas, clinical efficiency, clinical symptoms of relief time, lung function, hormone dosage were evaluated. Results The arterial blood gas analysis index, clinical effective rate, main clinical symptom relief time, pulmonary function and hormone dosage in the treatment group at 1 and 7 days after treatment were significantly better than those in the control group (P <0.05). No case of adverse reactions in the treatment group. Conclusion Budesonide combined with salbutamol nebulization can significantly improve the symptoms of asthma without obvious adverse reactions, which is worthy of clinical application.